Loading
YM
Yonghe Medical Group Co., Ltd. Stock: price and insider trades · Hong Kong
HK·Mcap HK$1.1B
No insider purchase over the last 90 days. The latest, by Han Zhimei, was filed 16 Dec 2025.
Yonghe Medical Group Co., Ltd.: what insiders have been doing
Every trade that managers of Yonghe Medical Group Co., Ltd. disclose to HKEX is tracked on this page. The last twelve months, up to 20 October 2026, brought 3 filings signed by 3 insiders.
Every open-market trade in the period is a purchase: 2 purchases, from 2 insiders, and not a single sale. The amount is not disclosed for 2 filings. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Among those who bought: 2 senior executives.
With 3 filings in twelve months, the company is quieter than the median of 4 filings across the 1,318 companies we follow on the same exchange. Looking back to 2021, when coverage begins, insiders filed 6 purchases and no sales.
The latest purchase dates back some time: it was published 309 days ago, on 16 December 2025. The median gap between a trade and its publication by HKEX is 3 days. Until a filing is published, the market cannot know about the trade.
In the same market, recent insider purchases at Sun Hung Kai Properties Ltd. and Xinyi Glass Holdings Ltd. also feature in our signals. Source: insider filings from HKEX. Past trades are no guide to future returns.
Insider Decl.
25
Thresholds
n/a
Buy Volume
n/a
6 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleHan Zhimei2 buys
Zhang Hui2 buys
Fundamental score
Ranked 1,508 of 26,280 companies
78.2
score / 100
Value88
Quality68
FCF yld45%
Earn yld6.9%
EV/EBITDA4.2x
ROE15%
Gross mgn66%
Net mgn4.1%
Debt/EBITDA1.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$2.13
Analyst consensus
2 analystsHK$2.46Target HK$3.18(+50%)HK$3.90
Income statement
RevenueHK$1.8B
Gross profitHK$1.2B66% margin
EBITDAHK$372.2M21% margin
Net incomeHK$73.7M6.3% margin
Valuation
PER (trailing)7.9x
PER (forward)6.9x
P/Book1.1x
Beta0.58
Balance sheet & cash
Market capHK$1.1B
Total debtHK$484.7M
Free Cash FlowHK$476.6M
Debt / Equity53%
Profitability & ownership
ROE15.5%
ROA6.8%
% insiders57.0%
% institutions20.4%
Last declaration on 16 December 2025
Declarations25 total
241,715 sharesShareXHKGHKEX:DA20251216E00014
Canonical exit: 13 Mar 2026 (T+90)
181,282 sharesShareXHKGHKEX:DA20241216E00074
Canonical exit: 13 Mar 2025 (T+90)
658,668 sharesShareXHKGHKEX:DA20240619E00281
181,282 sharesShareXHKGHKEX:DA20240619E00223
181,282 sharesShareXHKGHKEX:DA20240223E00202
Canonical exit: 12 Mar 2024 (T+90)
12,000,000 sharesShareXHKGHKEX:DA20220905E00129
658,668 sharesShareXHKGHKEX:DA20211222E00069
25 of 25 declarations
About Yonghe Medical Group Co., Ltd.
Yonghe Medical Group Co., Ltd. is a company listed on the Hong Kong Stock Exchange, specializing in the medical sector. It focuses on providing healthcare services and medical products.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations